Data / Form D filings / Modifi Biosciences, Inc.
Modifi Biosciences, Inc.: Form D filings
Modifi Biosciences, Inc., a biotechnology company in New Haven, CT, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on August 29, 2024, reports $995,503 sold of a $1 million offering to 39 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 55 CHURCH STREET, New Haven, CT, 06510
- Phone
- (203) 435-2255
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1922279
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 29, 2024 | New notice | $1,000,000 | $995,503 | $4,497 | 39 | Aug 19, 2024 | sec.gov |
| Aug 3, 2023 | Amendment | $11,424,038 | $10,474,023 | $950,015 | 40 | Apr 8, 2022 | sec.gov |
| Apr 19, 2022 | New notice | $6,424,036 | $5,674,036 | $750,000 | 32 | Apr 8, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kat L. Kayser-Bricker | Director | |
| Kevin L. Rakin | Executive Officer, Director | |
| Lucas L. de Breed | Director | |
| Ranjit L. Bindra | Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of Aug 26, 2024 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Modifi Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.